PJSC Promomed, ordinary share
PRMD, RU000A108JF7, 1-01-01622-G
CBONDSウォッチリストで投資を発見、保存、追跡
Cbondsウォッチリストを使用すれば、常に投資状況を最新の状態に保ち、意識的な意思決定が可能です!
Cbondsウォッチリストを使用すれば、常に投資状況を最新の状態に保ち、意識的な意思決定が可能です!
最も包括的なデータベースを探索
1 000 000
債券
100 000
株
175 910
ETF&投資信託
100 000
インデックス
最も効率的な方法でポートフォリオを追跡
|
PJSC Promomed is a biopharmaceutical company, whose portfolio includes blockbuster drugs and biotechnological drugs that have no analogues on the Russian market.
PJSC Promomed was established in 2021 in Moscow.
The company's structure includes an R&D Center and
...
PJSC Promomed is a biopharmaceutical company, whose portfolio includes blockbuster drugs and biotechnological drugs that have no analogues on the Russian market.
PJSC Promomed was established in 2021 in Moscow. The company's structure includes an R&D Center and the Biochemist plant. Thanks to this, Promomed implements the concept of a full production cycle. Promomed products are included in the state list of vital and essential medicines (VED). |